Tango Therapeutics (TNGX) Net Margin Growth (1y) (2021 - 2025)

Tango Therapeutics (TNGX) Net Margin Growth (1y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Tango Therapeutics 3.94 Bn 3.78 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 28,081.00
Jun 30, 2025 -109,285.00
Mar 31, 2025 -15,363.00
Dec 31, 2024 -34,918.00
Sep 30, 2024 -4,384.00
Jun 30, 2024 1,356.00
Mar 31, 2024 -10,016.00
Dec 31, 2023 -11,181.00
Sep 30, 2023 21,235.00
Jun 30, 2023 28,862.00
Mar 31, 2023 -4,795.00
Dec 31, 2022 -6,831.00
Sep 30, 2022 -13,116.00
Jun 30, 2022 -40,599.00
Mar 31, 2022 -24,822.00
Dec 31, 2021 -38,370.00
Sep 30, 2021 -5,063.00